218 related articles for article (PubMed ID: 31917263)
1. IRAK family in inflammatory autoimmune diseases.
Su LC; Xu WD; Huang AF
Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
Flannery S; Bowie AG
Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
[TBL] [Abstract][Full Text] [Related]
3. Interleukin Receptor Associated Kinase 1 Signaling and Its Association with Cardiovascular Diseases.
Zheng Y; He JQ
Rev Cardiovasc Med; 2022 Mar; 23(3):97. PubMed ID: 35345264
[TBL] [Abstract][Full Text] [Related]
4. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
5. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
Gan L; Li L
Immunol Res; 2006; 35(3):295-302. PubMed ID: 17172653
[TBL] [Abstract][Full Text] [Related]
6. The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.
Bai YR; Yang WG; Hou XH; Shen DD; Zhang SN; Li Y; Qiao YY; Wang SQ; Yuan S; Liu HM
Eur J Med Chem; 2023 Oct; 258():115606. PubMed ID: 37402343
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy.
Singer JW; Fleischman A; Al-Fayoumi S; Mascarenhas JO; Yu Q; Agarwal A
Oncotarget; 2018 Sep; 9(70):33416-33439. PubMed ID: 30279971
[TBL] [Abstract][Full Text] [Related]
8. IRAK1: a critical signaling mediator of innate immunity.
Gottipati S; Rao NL; Fung-Leung WP
Cell Signal; 2008 Feb; 20(2):269-76. PubMed ID: 17890055
[TBL] [Abstract][Full Text] [Related]
9. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
Martin MU; Wesche H
Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
[TBL] [Abstract][Full Text] [Related]
10. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
Rao N; Nguyen S; Ngo K; Fung-Leung WP
Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
[TBL] [Abstract][Full Text] [Related]
11. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.
Della Mina E; Borghesi A; Zhou H; Bougarn S; Boughorbel S; Israel L; Meloni I; Chrabieh M; Ling Y; Itan Y; Renieri A; Mazzucchelli I; Basso S; Pavone P; Falsaperla R; Ciccone R; Cerbo RM; Stronati M; Picard C; Zuffardi O; Abel L; Chaussabel D; Marr N; Li X; Casanova JL; Puel A
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E514-E523. PubMed ID: 28069966
[TBL] [Abstract][Full Text] [Related]
12. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
[TBL] [Abstract][Full Text] [Related]
13. IRAK Inhibitor Protects the Intestinal Tract of Necrotizing Enterocolitis by Inhibiting the Toll-Like Receptor (TLR) Inflammatory Signaling Pathway in Rats.
Hou Y; Lu X; Zhang Y
Med Sci Monit; 2018 May; 24():3366-3373. PubMed ID: 29784900
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor-associated kinase-M in gingival epithelial cells attenuates the inflammatory response elicited by Porphyromonas gingivalis.
Takahashi N; Honda T; Domon H; Nakajima T; Tabeta K; Yamazaki K
J Periodontal Res; 2010 Aug; 45(4):512-9. PubMed ID: 20412419
[TBL] [Abstract][Full Text] [Related]
15. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
[TBL] [Abstract][Full Text] [Related]
16. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
McDonald DR; Brown D; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor Pathways in Autoimmune Diseases.
Chen JQ; Szodoray P; Zeher M
Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
[TBL] [Abstract][Full Text] [Related]
18. IRAK-M regulates the inhibition of TLR-mediated macrophage immune response during late in vitro Leishmania donovani infection.
Srivastav S; Saha A; Barua J; Ukil A; Das PK
Eur J Immunol; 2015 Oct; 45(10):2787-97. PubMed ID: 26140693
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.
Sun J; Li N; Oh KS; Dutta B; Vayttaden SJ; Lin B; Ebert TS; De Nardo D; Davis J; Bagirzadeh R; Lounsbury NW; Pasare C; Latz E; Hornung V; Fraser ID
Sci Signal; 2016 Jan; 9(409):ra3. PubMed ID: 26732763
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
